Onconetix Inc (ONCO)
1.64
-0.08
(-4.65%)
USD |
NASDAQ |
Nov 14, 16:00
1.74
+0.10
(+6.10%)
After-Hours: 20:00
Onconetix Shareholders Equity (Quarterly): -35.81M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -35.81M |
| March 31, 2024 | -21.53M |
| December 31, 2023 | -5.602M |
| September 30, 2023 | 10.24M |
| June 30, 2023 | 13.08M |
| March 31, 2023 | 19.69M |
| December 31, 2022 | 22.39M |
| Date | Value |
|---|---|
| September 30, 2022 | 25.73M |
| June 30, 2022 | 20.58M |
| March 31, 2022 | 16.53M |
| December 31, 2021 | 1.447M |
| September 30, 2021 | 2.626M |
| December 31, 2020 | 4.734M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-35.81M
Minimum
Jun 2024
25.73M
Maximum
Sep 2022
5.700M
Average
10.24M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 59.46M |
| Total Liabilities (Quarterly) | 88.19M |
| Debt to Equity Ratio | -0.4216 |
| Current Ratio | 0.0988 |